Connect with us

Legal

Pfizer Facing South Florida Class Action Alleging Anti-Smoking Drug Chantix Increases Cancer Risk

Published

on

Pfizer was hit with a consumer class action Tuesday in Florida Southern District Court over the company’s generic version of the anti-smoking drug Chantix. The lawsuit, filed by Rivero Mestre LLP, claims that Pfizer’s drug, known generically as varenicline, contains carcinogens and is ineffective. Counsel have not yet appeared for the defendant. The case is 1:21-cv-23676, MSP Recovery Claims Series 44, LLC et al v. Pfizer, Inc.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.

MSP Recovery Claims Series 44, LLC et al v. Pfizer, Inc.

Advertisement

Legal

Contact Us

Please fill out the form below to connect with us, or call 878-425-3782.

ALL RIGHTS RESERVED © COPYRIGHT 2024 LIFEWALLET NETWORK